妇儿健康导刊2024，Vol.3Issue(2)：97-100,4.
乳腺癌改良根治术后复发转移1例报道
A case report of recurrence and metastasis of breast cancer after modified radical mastectomy
焦茹茹 1刘方丽1
作者信息
- 1. 山东省菏泽市牡丹人民医院综合治疗放疗病区,山东菏泽 274000
- 折叠
摘要
Abstract
Breast cancer is one of the most common malignant tumors in women.Among all subtypes of breast cancer,human epidermal growth factor receptor 2(HER2)positive breast cancer has a high degree of malignancy and a poor prognosis.At present,anti HER2 targeted therapy has become the main treatment method for HER2 positive breast cancer.This paper reported a case of HER2 positive breast cancer with recurrence and metastasis of breast cancer after modified radical mastectomy.The patient had lymph node metastasis,liver metastasis,bone metastasis,and lung metastasis five years after modified radical mastectomy for right breast cancer.After the treatment with the second-line treatment scheme of Inetetamab combined with Pyrotinib,the condition remained stable and the progression free survival period has reached 17 months at present.关键词
乳腺癌/术后复发/转移癌/伊尼妥单抗/吡咯替尼Key words
Breast cancer/Postoperative recurrence/Metastatic cancer/Inetetamab/Pyrotinib分类
医药卫生引用本文复制引用
焦茹茹,刘方丽..乳腺癌改良根治术后复发转移1例报道[J].妇儿健康导刊,2024,3(2):97-100,4.
